SEC Form 4 · accession 0001246360-15-003343
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey H Burbank
Officer — Chief Executive Officer · Director
Period of report
Oct 16, 2015
Accepted (ET)
Oct 16, 2015 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 16, 2015 | M | 10,000 | $2.11 | A | 886,756 | D | |
| Common Stock | Oct 16, 2015 | S | 10,000 | $15.59 | D | 876,756 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.11 | Oct 16, 2015 | M | 10,000 | D | Apr 5, 2009 | Mar 4, 2016 | Common Stock | 10,000 | 59,274 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2014.